Fulgent Genetics, Inc.: Form 8-K, filed Feb 28, 2023
Filed with the SEC on Feb 28, 2023 and accepted by EDGAR at Feb 28, 2023, 16:24 ET.
Items reported
- Item 2.02 Results of operations
- Item 7.01 Regulation FD disclosure
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0000950170-23-005124. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.